Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000950170-25-085490

10% owner sold 350,000 shares at $29.00 ($10,150,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Versant Venture Capital VI, L.P. 10% owner 2025-06-10 Sale −350,000 $29.00 $10,150,000 1,248,789 I
Open-market sales · 350,000 sh · avg $29.00 · $10,150,000
Loading xslF345X05/ownership.xml…